191 related articles for article (PubMed ID: 34439090)
1. Nuclear Pyruvate Kinase M2 (PKM2) Contributes to Phosphoserine Aminotransferase 1 (PSAT1)-Mediated Cell Migration in EGFR-Activated Lung Cancer Cells.
Biyik-Sit R; Kruer T; Dougherty S; Bradley JA; Wilkey DW; Merchant ML; Trent JO; Clem BF
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439090
[TBL] [Abstract][Full Text] [Related]
2. Phosphoserine Aminotransferase 1: A Metabolic Enzyme Target of Cancers.
Yang X; Li C; Chen Y
Curr Cancer Drug Targets; 2023; 23(3):171-186. PubMed ID: 36043756
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
[TBL] [Abstract][Full Text] [Related]
4. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma.
Luo MY; Zhou Y; Gu WM; Wang C; Shen NX; Dong JK; Lei HM; Tang YB; Liang Q; Zou JH; Xu L; Ma P; Zhuang G; Bi L; Xu L; Zhu L; Chen HZ; Shen Y
Cancer Res; 2022 Oct; 82(19):3516-3531. PubMed ID: 36193649
[TBL] [Abstract][Full Text] [Related]
6. PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells.
Yang Y; Wu J; Cai J; He Z; Yuan J; Zhu X; Li Y; Li M; Guan H
Int J Cancer; 2015 Feb; 136(4):E39-50. PubMed ID: 25142862
[TBL] [Abstract][Full Text] [Related]
7. Extracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway.
Hsu MC; Hung WC; Yamaguchi H; Lim SO; Liao HW; Tsai CH; Hung MC
Am J Cancer Res; 2016; 6(3):628-38. PubMed ID: 27152240
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cells.
Wang LY; Liu YP; Chen LG; Chen YL; Tan L; Liu JJ; Jazag A; Ren JL; Guleng B
PLoS One; 2013; 8(6):e67542. PubMed ID: 23840737
[TBL] [Abstract][Full Text] [Related]
9. Cytosolic PKM2 stabilizes mutant EGFR protein expression through regulating HSP90-EGFR association.
Yang YC; Cheng TY; Huang SM; Su CY; Yang PW; Lee JM; Chen CK; Hsiao M; Hua KT; Kuo ML
Oncogene; 2016 Jun; 35(26):3387-98. PubMed ID: 26500058
[TBL] [Abstract][Full Text] [Related]
10. Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.
Pan Y; Wang W; Huang S; Ni W; Wei Z; Cao Y; Yu S; Jia Q; Wu Y; Chai C; Zheng Q; Zhang L; Wang A; Sun Z; Huang S; Wang S; Chen W; Lu Y
J Cell Mol Med; 2019 Oct; 23(10):6846-6858. PubMed ID: 31343107
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.
Yuan S; Qiao T; Zhuang X; Chen W; Xing N; Zhang Q
Yonsei Med J; 2016 Nov; 57(6):1312-23. PubMed ID: 27593857
[TBL] [Abstract][Full Text] [Related]
12. Extracellular pyruvate kinase M2 facilitates cell migration by upregulating claudin-1 expression in colon cancer cells.
Kim H; Kim SH; Hwang D; An J; Chung HS; Yang EG; Kim SY
Biochem Cell Biol; 2020 Apr; 98(2):219-226. PubMed ID: 31545907
[TBL] [Abstract][Full Text] [Related]
13. PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC.
Wang X; Liang C; Yao X; Yang RH; Zhang ZS; Liu FY; Li WQ; Pei SH; Ma J; Xie SQ; Fang D
Front Pharmacol; 2020; 11():577108. PubMed ID: 33324209
[TBL] [Abstract][Full Text] [Related]
14. Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions.
Jin HO; Hong SE; Kim JY; Jang SK; Kim YS; Sim JH; Oh AC; Kim H; Hong YJ; Lee JK; Park IC
Anticancer Res; 2019 Dec; 39(12):6723-6730. PubMed ID: 31810937
[TBL] [Abstract][Full Text] [Related]
15. Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer.
Suzuki A; Puri S; Leland P; Puri A; Moudgil T; Fox BA; Puri RK; Joshi BH
PLoS One; 2019; 14(5):e0217131. PubMed ID: 31120964
[TBL] [Abstract][Full Text] [Related]
16. Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer.
Li Q; Zhang D; Chen X; He L; Li T; Xu X; Li M
Sci Rep; 2015 Nov; 5():16082. PubMed ID: 26542452
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNγ axis.
Chan YC; Chang YC; Chuang HH; Yang YC; Lin YF; Huang MS; Hsiao M; Yang CJ; Hua KT
Oncogene; 2020 Mar; 39(12):2509-2522. PubMed ID: 31988456
[TBL] [Abstract][Full Text] [Related]
18. Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo.
Meng MB; Wang HH; Guo WH; Wu ZQ; Zeng XL; Zaorsky NG; Shi HS; Qian D; Niu ZM; Jiang B; Zhao LJ; Yuan ZY; Wang P
Cancer Lett; 2015 Jan; 356(2 Pt B):985-93. PubMed ID: 25444918
[TBL] [Abstract][Full Text] [Related]
19. The synthetic oleanane triterpenoid CDDO-Me binds and inhibits pyruvate kinase M2.
Soares IN; Viana R; Trelford CB; Chan E; Thai B; Cino EA; Di Guglielmo GM
Pharmacol Rep; 2020 Jun; 72(3):631-640. PubMed ID: 32040844
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of
Huang SP; Chan YC; Huang SY; Lin YF
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
